دورية أكاديمية

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny

التفاصيل البيبلوغرافية
العنوان: B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny
المؤلفون: Anolik, Jennifer H. jennifer_anolik@urmc.rochester.edu, Friedberg, Jonathan W.1, Zheng, Bo1, Barnard, Jennifer1, Owen, Teresa1, Cushing, Emily1, Kelly, Jennifer1, Milner, Eric C.B.1, Fisher, Richard I.1, Sanz, Iñaki1
المصدر: Clinical Immunology. Feb2007, Vol. 122 Issue 2, p139-145. 7p.
مصطلحات موضوعية: *B cells, *RITUXIMAB, *LYMPHOMAS, *IMMUNOLOGY, *IMMUNE system, *BONE marrow transplantation
مستخلص: Abstract: The long-term immunologic effects of B cell depletion with rituximab and the characteristics of the reconstituting B cell pool in lymphoma patients are not well defined, despite the widespread usage of this therapy. Here we report that during the B cell reconstitution phase a majority of the peripheral blood B cells have an immature transitional phenotype (47.8%±25.2% vs. 4.4%±2.4% for normal controls, p <0.0001), similar to what has been described during the original ontogeny of the immune system and following bone marrow transplantation. Moreover, the recovery of the CD27+ memory B cell pool was delayed compared to normal B cell ontogeny, remaining below normal controls at 1 year post-rituximab (4.4%±3% vs. 31%±7%, p <0.0001). Expansion of functionally immature B cells and decreased memory B cells may contribute to an immunodeficient state in patients recovering from rituximab mediated B cell depletion, particularly with repeated treatment. [Copyright &y& Elsevier]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:15216616
DOI:10.1016/j.clim.2006.08.009